Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Dow
Boehringer Ingelheim
Merck
Baxter

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Zydus Pharms Usa Inc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA INC, and what generic and branded alternatives to ZYDUS PHARMS USA INC drugs are available?

ZYDUS PHARMS USA INC has thirty-seven approved drugs.

There are eighteen tentative approvals on ZYDUS PHARMS USA INC drugs.

Summary for Zydus Pharms Usa Inc
US Patents:0
Tradenames:33
Ingredients:33
NDAs:37

Drugs and US Patents for Zydus Pharms Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc MYCOPHENOLATE MOFETIL mycophenolate mofetil CAPSULE;ORAL 065433-001 May 4, 2009 DISCN No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc TOPIRAMATE topiramate TABLET;ORAL 078235-002 Mar 27, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc RISPERIDONE risperidone TABLET;ORAL 078040-005 Oct 16, 2008 AB RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 077100-003 Mar 5, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc ATOMOXETINE HYDROCHLORIDE atomoxetine hydrochloride CAPSULE;ORAL 079017-001 Sep 17, 2010 AB RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc TOPIRAMATE topiramate CAPSULE;ORAL 078877-002 Oct 14, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa Inc HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 040657-001 Sep 21, 2007 AB RX No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Colorcon
McKesson
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.